| LII |
LENNOX INTERNATIONAL INC |
Maskara Alok |
Director
Officer
|
2026-02-02 |
A - A |
3,953 |
0.00 |
0.00 |
28,844 |
| LII |
LENNOX INTERNATIONAL INC |
Maskara Alok |
Director
Officer
|
2026-02-02 |
A - A |
9,519 |
0.00 |
0.00 |
9,519 |
| ARQT |
Arcutis Biotherapeutics, Inc. |
Matsuda Masaru |
Officer
|
2026-02-02 |
S - D |
7,983 |
25.50 |
203,553.73 |
142,658 |
| ARQT |
Arcutis Biotherapeutics, Inc. |
Matsuda Masaru |
Officer
|
2026-02-02 |
S - D |
8,562 |
24.97 |
213,793.14 |
134,096 |
| ARQT |
Arcutis Biotherapeutics, Inc. |
Matsuda Masaru |
Officer
|
2026-02-02 |
S - D |
19,379 |
25.24 |
489,125.96 |
114,717 |
| ARQT |
Arcutis Biotherapeutics, Inc. |
Matsuda Masaru |
Officer
|
2026-02-02 |
S - D |
4,714 |
25.63 |
120,819.82 |
110,003 |
| AXL |
Dauch Corp |
May Christopher John |
Officer
|
2026-02-02 |
A - A |
287,879 |
0.00 |
0.00 |
1,014,968 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
M - A |
15,000 |
10.42 |
156,300.00 |
15,000 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
S - D |
600 |
44.20 |
26,523.00 |
14,400 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
S - D |
8,364 |
45.89 |
383,816.43 |
6,036 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
S - D |
5,936 |
46.37 |
275,271.32 |
100 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
S - D |
100 |
47.23 |
4,723.00 |
0 |
| MAZE |
Maze Therapeutics, Inc. |
Bernstein Harold |
|
2026-02-02 |
M - D |
15,000 |
0.00 |
0.00 |
297,407 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
M - A |
4,844 |
10.42 |
50,474.48 |
17,809 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
M - A |
156 |
10.42 |
1,625.52 |
17,965 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
S - D |
200 |
44.15 |
8,830.00 |
17,765 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
S - D |
4,064 |
46.03 |
187,067.95 |
13,701 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
S - D |
736 |
46.63 |
34,321.37 |
12,965 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
M - D |
4,844 |
0.00 |
0.00 |
3,025 |
| MAZE |
Maze Therapeutics, Inc. |
Bachrodt Amy |
|
2026-02-02 |
M - D |
156 |
0.00 |
0.00 |
41,333 |
| BCAX |
Bicara Therapeutics Inc. |
Mazumdar Claire |
Director
Officer
|
2026-02-02 |
A - A |
450,000 |
0.00 |
0.00 |
450,000 |
| AMLX |
Amylyx Pharmaceuticals, Inc. |
Mazzariello Gina |
|
2026-02-02 |
S - D |
3,448 |
14.65 |
50,515.61 |
144,693 |
| CRWV |
CoreWeave, Inc. |
McBee Brannin |
Officer
|
2026-02-02 |
C - A |
102,830 |
0.00 |
0.00 |
351,494 |
| CRWV |
CoreWeave, Inc. |
McBee Brannin |
Officer
|
2026-02-02 |
S - D |
21,442 |
89.03 |
1,909,071.32 |
330,052 |
| CRWV |
CoreWeave, Inc. |
McBee Brannin |
Officer
|
2026-02-02 |
S - D |
34,081 |
90.19 |
3,073,840.37 |
295,971 |